Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study III

Richard J. Andrassy, Daniel M. Hays, R. Beverly Raney, Eugene S. Wiener, Walter Lawrence, Thom E. Lobe, Cynthia A. Corpron, Malcolm Smith, Harold M. Maurer

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

The current management of pediatric vaginal and vulvar rhabdomyosarcoma (RMS) uses cytoreductive chemotherapy before surgical intervention. During the Intergroup Rhabdomyosarcoma Study (IRS)-III (1984 to 1988), 27 evaluable patients were entered on a preoperative chemotherapy protocol. Among 24 patients with vaginal primaries, 20 had an initial biopsy with gross residual (group III), 3 had resection with positive margins (group IIA) and 1 had metastatic disease (group IV). At subsequent surgery, 7 patients underwent partial or complete vaginectomy and 6 of them had no viable tumor identified in the specimen. Only 1 of these 7 patients underwent a cystectomy, whereas 5 underwent hysterectomy. Seventeen patients in this group have no evidence of disease 66 to 108 months after diagnosis; 2 died of chemotoxicity and 1 of unknown causes after achieving a complete response. Ten of these 17 patients were treated with biopsy and chemotherapy only. Four of these 10 had radiotherapy as well. All group IIA patients have no evidence of disease. The 1 group IV patient had rapidly progressive disease with early death. This primary chemotherapy protocol resulted in less need for operative intervention or irradiation compared with previous experience. There was no local recurrence, and 20 of 24 patients remain continuously relapsefree with no evidence of disease. All 3 patients with vulvar primaries were treated by wide local excision and chemotherapy and have no evidence of disease. Conservative surgical intervention for vaginal RMS with primary chemotherapy and adjunctive radiation when necessary appears to result in excellent disease-free survival.

Original languageEnglish (US)
Pages (from-to)1034-1037
Number of pages4
JournalJournal of pediatric surgery
Volume30
Issue number7
DOIs
StatePublished - Jul 1995

Fingerprint

Rhabdomyosarcoma
Pediatrics
Drug Therapy
Conservative Treatment
Biopsy
Cystectomy
Hysterectomy
Disease-Free Survival
Radiotherapy
Radiation
Recurrence

Keywords

  • Rhabdomyosarcoma
  • pediatric
  • vaginal vulvar

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma : A report from the intergroup rhabdomyosarcoma study III. / Andrassy, Richard J.; Hays, Daniel M.; Raney, R. Beverly; Wiener, Eugene S.; Lawrence, Walter; Lobe, Thom E.; Corpron, Cynthia A.; Smith, Malcolm; Maurer, Harold M.

In: Journal of pediatric surgery, Vol. 30, No. 7, 07.1995, p. 1034-1037.

Research output: Contribution to journalArticle

Andrassy, RJ, Hays, DM, Raney, RB, Wiener, ES, Lawrence, W, Lobe, TE, Corpron, CA, Smith, M & Maurer, HM 1995, 'Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study III', Journal of pediatric surgery, vol. 30, no. 7, pp. 1034-1037. https://doi.org/10.1016/0022-3468(95)90336-4
Andrassy, Richard J. ; Hays, Daniel M. ; Raney, R. Beverly ; Wiener, Eugene S. ; Lawrence, Walter ; Lobe, Thom E. ; Corpron, Cynthia A. ; Smith, Malcolm ; Maurer, Harold M. / Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma : A report from the intergroup rhabdomyosarcoma study III. In: Journal of pediatric surgery. 1995 ; Vol. 30, No. 7. pp. 1034-1037.
@article{25d2be35d49a432e9298a91bbb0f2465,
title = "Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study III",
abstract = "The current management of pediatric vaginal and vulvar rhabdomyosarcoma (RMS) uses cytoreductive chemotherapy before surgical intervention. During the Intergroup Rhabdomyosarcoma Study (IRS)-III (1984 to 1988), 27 evaluable patients were entered on a preoperative chemotherapy protocol. Among 24 patients with vaginal primaries, 20 had an initial biopsy with gross residual (group III), 3 had resection with positive margins (group IIA) and 1 had metastatic disease (group IV). At subsequent surgery, 7 patients underwent partial or complete vaginectomy and 6 of them had no viable tumor identified in the specimen. Only 1 of these 7 patients underwent a cystectomy, whereas 5 underwent hysterectomy. Seventeen patients in this group have no evidence of disease 66 to 108 months after diagnosis; 2 died of chemotoxicity and 1 of unknown causes after achieving a complete response. Ten of these 17 patients were treated with biopsy and chemotherapy only. Four of these 10 had radiotherapy as well. All group IIA patients have no evidence of disease. The 1 group IV patient had rapidly progressive disease with early death. This primary chemotherapy protocol resulted in less need for operative intervention or irradiation compared with previous experience. There was no local recurrence, and 20 of 24 patients remain continuously relapsefree with no evidence of disease. All 3 patients with vulvar primaries were treated by wide local excision and chemotherapy and have no evidence of disease. Conservative surgical intervention for vaginal RMS with primary chemotherapy and adjunctive radiation when necessary appears to result in excellent disease-free survival.",
keywords = "Rhabdomyosarcoma, pediatric, vaginal vulvar",
author = "Andrassy, {Richard J.} and Hays, {Daniel M.} and Raney, {R. Beverly} and Wiener, {Eugene S.} and Walter Lawrence and Lobe, {Thom E.} and Corpron, {Cynthia A.} and Malcolm Smith and Maurer, {Harold M.}",
year = "1995",
month = "7",
doi = "10.1016/0022-3468(95)90336-4",
language = "English (US)",
volume = "30",
pages = "1034--1037",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Conservative surgical management of vaginal and vulvar pediatric rhabdomyosarcoma

T2 - A report from the intergroup rhabdomyosarcoma study III

AU - Andrassy, Richard J.

AU - Hays, Daniel M.

AU - Raney, R. Beverly

AU - Wiener, Eugene S.

AU - Lawrence, Walter

AU - Lobe, Thom E.

AU - Corpron, Cynthia A.

AU - Smith, Malcolm

AU - Maurer, Harold M.

PY - 1995/7

Y1 - 1995/7

N2 - The current management of pediatric vaginal and vulvar rhabdomyosarcoma (RMS) uses cytoreductive chemotherapy before surgical intervention. During the Intergroup Rhabdomyosarcoma Study (IRS)-III (1984 to 1988), 27 evaluable patients were entered on a preoperative chemotherapy protocol. Among 24 patients with vaginal primaries, 20 had an initial biopsy with gross residual (group III), 3 had resection with positive margins (group IIA) and 1 had metastatic disease (group IV). At subsequent surgery, 7 patients underwent partial or complete vaginectomy and 6 of them had no viable tumor identified in the specimen. Only 1 of these 7 patients underwent a cystectomy, whereas 5 underwent hysterectomy. Seventeen patients in this group have no evidence of disease 66 to 108 months after diagnosis; 2 died of chemotoxicity and 1 of unknown causes after achieving a complete response. Ten of these 17 patients were treated with biopsy and chemotherapy only. Four of these 10 had radiotherapy as well. All group IIA patients have no evidence of disease. The 1 group IV patient had rapidly progressive disease with early death. This primary chemotherapy protocol resulted in less need for operative intervention or irradiation compared with previous experience. There was no local recurrence, and 20 of 24 patients remain continuously relapsefree with no evidence of disease. All 3 patients with vulvar primaries were treated by wide local excision and chemotherapy and have no evidence of disease. Conservative surgical intervention for vaginal RMS with primary chemotherapy and adjunctive radiation when necessary appears to result in excellent disease-free survival.

AB - The current management of pediatric vaginal and vulvar rhabdomyosarcoma (RMS) uses cytoreductive chemotherapy before surgical intervention. During the Intergroup Rhabdomyosarcoma Study (IRS)-III (1984 to 1988), 27 evaluable patients were entered on a preoperative chemotherapy protocol. Among 24 patients with vaginal primaries, 20 had an initial biopsy with gross residual (group III), 3 had resection with positive margins (group IIA) and 1 had metastatic disease (group IV). At subsequent surgery, 7 patients underwent partial or complete vaginectomy and 6 of them had no viable tumor identified in the specimen. Only 1 of these 7 patients underwent a cystectomy, whereas 5 underwent hysterectomy. Seventeen patients in this group have no evidence of disease 66 to 108 months after diagnosis; 2 died of chemotoxicity and 1 of unknown causes after achieving a complete response. Ten of these 17 patients were treated with biopsy and chemotherapy only. Four of these 10 had radiotherapy as well. All group IIA patients have no evidence of disease. The 1 group IV patient had rapidly progressive disease with early death. This primary chemotherapy protocol resulted in less need for operative intervention or irradiation compared with previous experience. There was no local recurrence, and 20 of 24 patients remain continuously relapsefree with no evidence of disease. All 3 patients with vulvar primaries were treated by wide local excision and chemotherapy and have no evidence of disease. Conservative surgical intervention for vaginal RMS with primary chemotherapy and adjunctive radiation when necessary appears to result in excellent disease-free survival.

KW - Rhabdomyosarcoma

KW - pediatric

KW - vaginal vulvar

UR - http://www.scopus.com/inward/record.url?scp=0029146896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029146896&partnerID=8YFLogxK

U2 - 10.1016/0022-3468(95)90336-4

DO - 10.1016/0022-3468(95)90336-4

M3 - Article

C2 - 7472927

AN - SCOPUS:0029146896

VL - 30

SP - 1034

EP - 1037

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 7

ER -